Literature DB >> 9287338

GAS6 mediates adhesion of cells expressing the receptor tyrosine kinase Axl.

P McCloskey1, Y W Fridell, E Attar, J Villa, Y Jin, B Varnum, E T Liu.   

Abstract

Axl is a receptor tyrosine kinase that contains both immunoglobulin and fibronectin III repeats in its extracellular domain reminiscent of cell adhesion molecules. Expression of the receptor tyrosine kinase Axl in the 32D myeloid cell line permits aggregation of cells in response to treatment with the native ligand GAS6; this aggregation was not observed in untreated 32D-Axl cells nor in treated parental cells. This aggregation can be blocked by the addition of excess Axl extracellular domain peptide and does not require intracellular Axl kinase activity. Cell surface binding activity of GAS6 was mapped to distinct plasma membrane interacting domains that are separate from the GAS6 motifs that engage the Axl receptor. This suggests that aggregation is mediated by a heterotypic intercellular mechanism whereby cell-bound GAS6 interacts with Axl receptor on an adjacent cell. This mechanism is supported by our observation that GAS6 binds to 32D parental cells which then permits their aggregation with untreated 32D-Axl cells. We have recently demonstrated that the GAS6-Axl interaction does not initiate mitogenesis in 32D cells. When considered with the adhesion results, these data suggest that an important biological function of the Axl-GAS6 interaction is to mediate cell-cell binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9287338     DOI: 10.1074/jbc.272.37.23285

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Novel mechanism for gonadotropin-releasing hormone neuronal migration involving Gas6/Ark signaling to p38 mitogen-activated protein kinase.

Authors:  Melissa P Allen; Daniel A Linseman; Hiroshi Udo; Mei Xu; Jerome B Schaack; Brian Varnum; Eric R Kandel; Kim A Heidenreich; Margaret E Wierman
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

2.  Gas6 induces growth, beta-catenin stabilization, and T-cell factor transcriptional activation in contact-inhibited C57 mammary cells.

Authors:  S Goruppi; C Chiaruttini; M E Ruaro; B Varnum; C Schneider
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

3.  Hematopoietic progenitor cells grow on 3T3 fibroblast monolayers that overexpress growth arrest-specific gene-6 (GAS6).

Authors:  S P Dormady; X M Zhang; R S Basch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

4.  Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway.

Authors:  K O'Donnell; I C Harkes; L Dougherty; I P Wicks
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

5.  Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum.

Authors:  Vadim Budagian; Elena Bulanova; Zane Orinska; Erwin Duitman; Katja Brandt; Andreas Ludwig; Dieter Hartmann; Greg Lemke; Paul Saftig; Silvia Bulfone-Paus
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

6.  Essential role of Gas6 for glomerular injury in nephrotoxic nephritis.

Authors:  Motoko Yanagita; Yoshikazu Ishimoto; Hidenori Arai; Kojiro Nagai; Tsuyoshi Ito; Toru Nakano; David J Salant; Atsushi Fukatsu; Toshio Doi; Toru Kita
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

7.  Biological properties and gene expression associated with metastatic potential of human osteosarcoma.

Authors:  Tetsuhiro Nakano; Masachika Tani; Yasunori Ishibashi; Kenji Kimura; Yong-Bum Park; Natsuko Imaizumi; Hiroyuki Tsuda; Kazuhiko Aoyagi; Hiroki Sasaki; Susumu Ohwada; Jun Yokota
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 8.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

9.  Role of axl in preeclamptic EPCs functions.

Authors:  Ying Hu; Xiao-Ping Liu; Xiao-Xia Liu; Yan-Fang Zheng; Wei-Fang Liu; Ming-Lian Luo; Hui Gao; Ying Zhao; Li Zou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

10.  AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer.

Authors:  Haley D Axelrod; Kenneth C Valkenburg; Sarah R Amend; Jessica L Hicks; Princy Parsana; Gonzalo Torga; Angelo M DeMarzo; Kenneth J Pienta
Journal:  Mol Cancer Res       Date:  2018-10-05       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.